ZNF75D
gene geneOn this page
Also known as ZKSCAN24D8C6ZSCAN28
Summary
ZNF75D (zinc finger protein 75D, HGNC:13145) is a protein-coding gene on chromosome Xq26.3, encoding Zinc finger protein 75D (P51815). May be involved in transcriptional regulation.
This gene encodes a protein that likely functions as a transcription factor. The protein, which belongs to the ZNF75 family, includes an N-terminal SCAN domain, a KRAB box, and five C2H2-type zinc finger motifs. Another functional gene belonging to this family is located on chromosome 16, while pseudogenes have been identified on chromosomes 11 and 12. Alternative splicing results in multiple transcripts variants.
Source: NCBI Gene 7626 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 114 total
- MANE Select transcript:
NM_007131
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:13145 |
| Approved symbol | ZNF75D |
| Name | zinc finger protein 75D |
| Location | Xq26.3 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | ZKSCAN24, D8C6, ZSCAN28 |
| Ensembl gene | ENSG00000186376 |
| Ensembl biotype | protein_coding |
| OMIM | 314997 |
| Entrez | 7626 |
Gene structure
Transcript identifiers
Ensembl transcripts: 14 — 12 protein_coding, 2 protein_coding_CDS_not_defined
ENST00000370764, ENST00000370766, ENST00000469456, ENST00000494295, ENST00000865785, ENST00000865786, ENST00000865787, ENST00000865788, ENST00000865789, ENST00000865790, ENST00000865791, ENST00000942296, ENST00000942297, ENST00000942298
RefSeq mRNA: 2 — MANE Select: NM_007131
NM_001185063, NM_007131
CCDS: CCDS14648, CCDS55503
Canonical transcript exons
ENST00000370766 — 7 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001257659 | 135292281 | 135292473 |
| ENSE00001257694 | 135295768 | 135296039 |
| ENSE00001257730 | 135291472 | 135291563 |
| ENSE00001257745 | 135285791 | 135287846 |
| ENSE00001453586 | 135293730 | 135294258 |
| ENSE00001635051 | 135291009 | 135291135 |
| ENSE00001889449 | 135341768 | 135344109 |
Expression profiles
Bgee: expression breadth ubiquitous, 233 present calls, max score 86.97.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 5.2668 / max 60.9877, expressed in 1626 samples.
FANTOM5 promoters (3 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 200619 | 3.6226 | 1469 |
| 200620 | 1.4706 | 869 |
| 200618 | 0.1736 | 91 |
Top tissues by expression
274 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 86.97 | gold quality |
| right adrenal gland cortex | UBERON:0035827 | 86.60 | gold quality |
| right adrenal gland | UBERON:0001233 | 86.29 | gold quality |
| left adrenal gland | UBERON:0001234 | 84.79 | gold quality |
| left adrenal gland cortex | UBERON:0035825 | 84.79 | gold quality |
| adrenal cortex | UBERON:0001235 | 84.54 | gold quality |
| adrenal tissue | UBERON:0018303 | 83.96 | gold quality |
| adrenal gland | UBERON:0002369 | 83.85 | gold quality |
| buccal mucosa cell | CL:0002336 | 82.82 | silver quality |
| body of pancreas | UBERON:0001150 | 82.54 | gold quality |
| spleen | UBERON:0002106 | 82.42 | gold quality |
| granulocyte | CL:0000094 | 82.03 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 81.74 | gold quality |
| right lobe of liver | UBERON:0001114 | 81.47 | gold quality |
| right uterine tube | UBERON:0001302 | 81.24 | gold quality |
| left lobe of thyroid gland | UBERON:0001120 | 80.91 | gold quality |
| metanephros cortex | UBERON:0010533 | 80.65 | gold quality |
| right lobe of thyroid gland | UBERON:0001119 | 80.50 | gold quality |
| thyroid gland | UBERON:0002046 | 80.30 | gold quality |
| prostate gland | UBERON:0002367 | 79.77 | gold quality |
| small intestine Peyer’s patch | UBERON:0003454 | 79.40 | gold quality |
| right lung | UBERON:0002167 | 79.33 | gold quality |
| endometrium epithelium | UBERON:0004811 | 79.32 | gold quality |
| body of stomach | UBERON:0001161 | 79.29 | gold quality |
| right ovary | UBERON:0002118 | 79.12 | gold quality |
| ventricular zone | UBERON:0003053 | 78.85 | gold quality |
| monocyte | CL:0000576 | 78.84 | gold quality |
| leukocyte | CL:0000738 | 78.76 | gold quality |
| transverse colon | UBERON:0001157 | 78.71 | gold quality |
| pancreas | UBERON:0001264 | 78.67 | gold quality |
Single-cell (SCXA)
Detected in 2 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-MTAB-6386 | no | 526.52 |
| E-ANND-3 | no | 4.81 |
Regulation
Is transcription factor: yes
JASPAR motifs
| Motif | Name | Family |
|---|---|---|
| MA1601.1 | ZNF75D | More than 3 adjacent zinc fingers |
| MA1601.2 | ZNF75D | More than 3 adjacent zinc fingers |
JASPAR matrix evidence (PMIDs): PMID:28473536
miRNA regulators (miRDB)
55 targeting ZNF75D, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-340-5P | 100.00 | 72.50 | 4437 |
| HSA-MIR-1250-3P | 99.96 | 70.04 | 4038 |
| HSA-MIR-450B-5P | 99.92 | 71.48 | 3175 |
| HSA-MIR-6809-3P | 99.91 | 71.45 | 3814 |
| HSA-MIR-4753-3P | 99.90 | 71.03 | 3786 |
| HSA-MIR-153-5P | 99.89 | 73.86 | 6317 |
| HSA-MIR-95-5P | 99.89 | 72.17 | 3973 |
| HSA-MIR-4307 | 99.82 | 70.45 | 3374 |
| HSA-MIR-4799-5P | 99.82 | 70.60 | 2663 |
| HSA-MIR-577 | 99.78 | 69.13 | 2479 |
| HSA-MIR-1283 | 99.69 | 72.42 | 3009 |
| HSA-MIR-3660 | 99.68 | 67.33 | 1149 |
| HSA-MIR-4526 | 99.68 | 67.07 | 1136 |
| HSA-MIR-9851-3P | 99.63 | 69.68 | 1110 |
| HSA-MIR-5584-5P | 99.49 | 68.22 | 2814 |
| HSA-MIR-4728-3P | 99.47 | 68.94 | 981 |
| HSA-MIR-942-5P | 99.41 | 68.40 | 1977 |
| HSA-MIR-4797-5P | 99.39 | 68.01 | 1354 |
| HSA-MIR-32-3P | 99.36 | 68.20 | 2517 |
| HSA-MIR-593-5P | 99.34 | 69.50 | 965 |
| HSA-MIR-145-3P | 99.33 | 67.66 | 764 |
| HSA-MIR-4652-3P | 99.33 | 70.02 | 2742 |
| HSA-MIR-1206 | 99.30 | 69.32 | 1016 |
| HSA-MIR-6719-3P | 99.29 | 67.78 | 1387 |
| HSA-MIR-3160-5P | 99.28 | 69.07 | 1938 |
| HSA-MIR-5582-5P | 99.27 | 71.42 | 1879 |
| HSA-MIR-296-3P | 99.21 | 66.56 | 474 |
| HSA-MIR-5701 | 98.97 | 69.54 | 1502 |
| HSA-MIR-6737-3P | 98.95 | 68.56 | 1577 |
| HSA-MIR-7157-3P | 98.95 | 68.70 | 1582 |
Cross-species orthologs
0 orthologs
Paralogs (30): ZNF263 (ENSG00000006194), ZNF213 (ENSG00000085644), ZNF500 (ENSG00000103199), ZKSCAN1 (ENSG00000106261), ZNF205 (ENSG00000122386), ZSCAN9 (ENSG00000137185), PGBD1 (ENSG00000137338), ZNF215 (ENSG00000149054), ZSCAN12 (ENSG00000158691), ZNF394 (ENSG00000160908), ZNF75A (ENSG00000162086), ZSCAN21 (ENSG00000166529), ZNF232 (ENSG00000167840), ZNF24 (ENSG00000172466), ZNF449 (ENSG00000173275), ZSCAN4 (ENSG00000180532), ZSCAN22 (ENSG00000182318), ZNF396 (ENSG00000186496), ZNF397 (ENSG00000186812), ZSCAN30 (ENSG00000186814), ZKSCAN4 (ENSG00000187626), ZSCAN23 (ENSG00000187987), ZKSCAN3 (ENSG00000189298), ZSCAN16 (ENSG00000196812), ZSCAN25 (ENSG00000197037), ZSCAN26 (ENSG00000197062), ZNF165 (ENSG00000197279), ZKSCAN8 (ENSG00000198315), ZSCAN31 (ENSG00000235109), ZNF853 (ENSG00000236609)
Protein
Protein identifiers
Zinc finger protein 75D — P51815 (reviewed: P51815)
Alternative names: Zinc finger protein 75, Zinc finger protein 82
All UniProt accessions (1): P51815
UniProt curated annotations — full annotation on UniProt →
Function. May be involved in transcriptional regulation.
Subcellular location. Nucleus.
Similarity. Belongs to the krueppel C2H2-type zinc-finger protein family.
Isoforms (2)
| UniProt ID | Names | Canonical? |
|---|---|---|
| P51815-1 | 1 | yes |
| P51815-2 | 2 |
RefSeq proteins (2): NP_001171992, NP_009062* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR001909 | KRAB | Domain |
| IPR003309 | SCAN_dom | Domain |
| IPR013087 | Znf_C2H2_type | Domain |
| IPR036051 | KRAB_dom_sf | Homologous_superfamily |
| IPR036236 | Znf_C2H2_sf | Homologous_superfamily |
| IPR038269 | SCAN_sf | Homologous_superfamily |
Pfam: PF00096, PF01352, PF02023
UniProt features (14 total): zinc finger region 5, domain 2, compositionally biased region 2, region of interest 2, chain 1, splice variant 1, sequence conflict 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-P51815-F1 | 63.21 | 0.08 |
Function
Pathways and Gene Ontology
Reactome pathways
1 pathways
| ID | Pathway |
|---|---|
| R-HSA-212436 | Generic Transcription Pathway |
MSigDB gene sets: 60 (showing top):
BEGUM_TARGETS_OF_PAX3_FOXO1_FUSION_UP, MODULE_285, GRYDER_PAX3FOXO1_ENHANCERS_IN_TADS, BLALOCK_ALZHEIMERS_DISEASE_DN, GOMF_SEQUENCE_SPECIFIC_DNA_BINDING, LIU_PROSTATE_CANCER_DN, chrXq26, GOMF_TRANSCRIPTION_REGULATOR_ACTIVITY, RBM34_TARGET_GENES, SFMBT1_TARGET_GENES, ZNF407_TARGET_GENES, ZNF423_TARGET_GENES, MIR153_5P, MIR1250_3P, MIR4652_3P
GO Biological Process (2): regulation of transcription by RNA polymerase II (GO:0006357), regulation of DNA-templated transcription (GO:0006355)
GO Molecular Function (5): RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978), DNA-binding transcription factor activity, RNA polymerase II-specific (GO:0000981), zinc ion binding (GO:0008270), DNA binding (GO:0003677), metal ion binding (GO:0046872)
GO Cellular Component (1): nucleus (GO:0005634)
Reactome top-level categories
Rollup of top-1 pathways:
| Category | Pathways |
|---|---|
| RNA Polymerase II Transcription | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| RNA polymerase II transcription regulatory region sequence-specific DNA binding | 2 |
| regulation of DNA-templated transcription | 1 |
| transcription by RNA polymerase II | 1 |
| DNA-templated transcription | 1 |
| regulation of gene expression | 1 |
| regulation of RNA biosynthetic process | 1 |
| cis-regulatory region sequence-specific DNA binding | 1 |
| chromatin | 1 |
| DNA-binding transcription factor activity | 1 |
| regulation of transcription by RNA polymerase II | 1 |
| transition metal ion binding | 1 |
| nucleic acid binding | 1 |
| cation binding | 1 |
| intracellular membrane-bounded organelle | 1 |
Protein interactions and networks
STRING
900 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| ZNF75D | ZNF274 | Q96GC6 | 585 |
| ZNF75D | PAPLN | O95428 | 478 |
| ZNF75D | DNAJC16 | Q9Y2G8 | 474 |
| ZNF75D | CCDC59 | Q9P031 | 459 |
| ZNF75D | ELP4 | Q96EB1 | 449 |
| ZNF75D | NEK8 | Q86SG6 | 397 |
| ZNF75D | SC5D | O75845 | 380 |
| ZNF75D | MAGEH1 | Q9H213 | 376 |
| ZNF75D | NHLH2 | Q02577 | 372 |
| ZNF75D | NEK9 | Q8TD19 | 370 |
| ZNF75D | ATP10A | O60312 | 366 |
| ZNF75D | PURA | Q00577 | 351 |
| ZNF75D | PCSK1 | P29120 | 349 |
| ZNF75D | CCDC85B | Q15834 | 346 |
| ZNF75D | ZC3H6 | P61129 | 333 |
IntAct
4 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| ZNF75D | MRPS14 | psi-mi:“MI:0914”(association) | 0.350 |
| sthA | ZNF75D | psi-mi:“MI:0915”(physical association) | 0.000 |
| ZNF75D | psi-mi:“MI:0915”(physical association) | 0.000 |
BioGRID (2): ZNF75D (Affinity Capture-MS), ZNF75D (Affinity Capture-RNA)
ESM2 similar proteins: A1YEQ3, A1YEV9, A1YFW6, A1YG26, A1YG48, A1YG60, A2T6W2, A2T712, A2T736, A2T7L7, A6QNZ0, O14978, O15535, O95125, P17022, P17029, P49910, P51815, P59923, Q07231, Q15776, Q16670, Q1LZ87, Q3MJ62, Q3URR7, Q4KLI1, Q4R8H9, Q53GI3, Q5R670, Q5R741, Q5RJ54, Q63HK3, Q642B9, Q6P9G9, Q810A1, Q86W11, Q8BGS3, Q8CF60, Q8NF99, Q92670
Diamond homologs: A0JPK3, A8MT65, C9JN71, E9QAG8, G3X9G7, O75820, P16373, P16374, P16415, P17017, P17024, P17025, P51815, P52737, Q08AG5, Q08ER8, Q0D2J5, Q15973, Q2M218, Q3KP31, Q3V080, Q494X3, Q4R4C7, Q5MYW4, Q5R9F0, Q5R9S5, Q5REI6, Q5REK1, Q68EA5, Q6P560, Q6P5C7, Q6ZQV5, Q7L945, Q86T29, Q8BGV5, Q8C6P8, Q8IYI8, Q8IZC7, Q8N7K0, Q8N972
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
114 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 41 |
| Likely benign | 8 |
| Benign | 2 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
1237 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| X:135291005:TTACC:T | donor_loss | 1.0000 |
| X:135291006:TA:T | donor_loss | 1.0000 |
| X:135291007:A:C | donor_loss | 1.0000 |
| X:135291008:C:CA | donor_loss | 1.0000 |
| X:135291131:AAACT:A | acceptor_gain | 1.0000 |
| X:135291132:AACT:A | acceptor_gain | 1.0000 |
| X:135291134:CT:C | acceptor_gain | 1.0000 |
| X:135291136:C:CC | acceptor_gain | 1.0000 |
| X:135292275:CCTCA:C | donor_loss | 1.0000 |
| X:135292276:CTCA:C | donor_loss | 1.0000 |
| X:135292277:TCA:T | donor_loss | 1.0000 |
| X:135292278:CACCT:C | donor_loss | 1.0000 |
| X:135292279:A:T | donor_loss | 1.0000 |
| X:135343323:CAG:C | donor_gain | 1.0000 |
| X:135291041:A:AC | donor_gain | 0.9900 |
| X:135291133:ACTCT:A | acceptor_gain | 0.9900 |
| X:135291135:TC:T | acceptor_loss | 0.9900 |
| X:135291136:CTAAA:C | acceptor_loss | 0.9900 |
| X:135291137:T:A | acceptor_loss | 0.9900 |
| X:135291561:CAG:C | acceptor_gain | 0.9900 |
| X:135292280:CCT:C | donor_gain | 0.9900 |
| X:135292474:CTAG:C | acceptor_loss | 0.9900 |
| X:135294257:CA:C | acceptor_gain | 0.9900 |
| X:135294259:C:CC | acceptor_gain | 0.9900 |
| X:135343308:A:AC | donor_gain | 0.9900 |
| X:135343309:C:CC | donor_gain | 0.9900 |
| X:135291034:AT:A | donor_gain | 0.9800 |
| X:135291134:CTCT:C | acceptor_gain | 0.9800 |
| X:135292472:ACCT:A | acceptor_gain | 0.9800 |
| X:135292473:CCT:C | acceptor_gain | 0.9800 |
AlphaMissense
3410 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| X:135287296:G:C | F458L | 1.000 |
| X:135287296:G:T | F458L | 1.000 |
| X:135287298:A:G | F458L | 1.000 |
| X:135287380:A:C | F430L | 1.000 |
| X:135287380:A:T | F430L | 1.000 |
| X:135287382:A:G | F430L | 1.000 |
| X:135287279:A:G | L464P | 0.999 |
| X:135287297:A:G | F458S | 0.999 |
| X:135287341:G:C | H443Q | 0.999 |
| X:135287341:G:T | H443Q | 0.999 |
| X:135287464:A:C | F402L | 0.999 |
| X:135287464:A:T | F402L | 0.999 |
| X:135287466:A:G | F402L | 0.999 |
| X:135287548:G:C | F374L | 0.999 |
| X:135287548:G:T | F374L | 0.999 |
| X:135287550:A:G | F374L | 0.999 |
| X:135287212:A:C | F486L | 0.998 |
| X:135287212:A:T | F486L | 0.998 |
| X:135287214:A:G | F486L | 0.998 |
| X:135287269:G:C | H467Q | 0.998 |
| X:135287269:G:T | H467Q | 0.998 |
| X:135287343:G:C | H443D | 0.998 |
| X:135287353:G:C | H439Q | 0.998 |
| X:135287353:G:T | H439Q | 0.998 |
| X:135287363:A:G | L436P | 0.998 |
| X:135287381:A:G | F430S | 0.998 |
| X:135287267:T:G | Q468P | 0.997 |
| X:135287271:G:C | H467D | 0.997 |
| X:135287323:A:C | F449L | 0.997 |
| X:135287323:A:T | F449L | 0.997 |
dbSNP variants (sampled 300 via entrez): RS1000015206 (X:135285173 G>A), RS1000123787 (X:135275937 C>A), RS1000125013 (X:135345515 G>A), RS1000236163 (X:135284526 T>G), RS1000308748 (X:135276671 G>A), RS1000572361 (X:135298856 G>T), RS1000641570 (X:135319087 C>A,T), RS1000680841 (X:135259824 C>T), RS1000701019 (X:135328728 C>A), RS1000739274 (X:135338448 C>T), RS1000909324 (X:135278485 C>G,T), RS1000913397 (X:135268028 G>T), RS1000933549 (X:135318803 T>C), RS1000963877 (X:135267522 G>T), RS1001011522 (X:135289647 C>G)
Disease associations
OMIM: gene MIM:314997 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
19 total (human), top 19 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Benzo(a)pyrene | affects expression, affects methylation, decreases expression, increases methylation | 4 |
| Aflatoxin B1 | decreases methylation, increases methylation | 2 |
| methylmercuric chloride | decreases expression | 1 |
| triphenyl phosphate | affects expression | 1 |
| geraniol | increases expression | 1 |
| methylselenic acid | increases expression | 1 |
| sodium arsenite | decreases expression | 1 |
| butyraldehyde | decreases expression | 1 |
| potassium chromate(VI) | decreases expression | 1 |
| CGP 52608 | affects binding, increases reaction | 1 |
| abrine | decreases expression | 1 |
| Resveratrol | affects cotreatment, increases expression | 1 |
| Acetaminophen | decreases expression | 1 |
| Doxorubicin | decreases expression | 1 |
| Phthalic Acids | decreases methylation | 1 |
| Plant Extracts | affects cotreatment, increases expression | 1 |
| Tretinoin | increases expression | 1 |
| Valproic Acid | increases methylation | 1 |
| Cyclosporine | increases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.